Company news
BioElectronics Corp. news in 2017
BioElectronics Corp.'s news releases, calls and decks from 2017, newest first.
BioElectronics Announces ActiPatch: Over-The-Counter Alternative to Opioids
December 12, 2017
BioElectronics Announces the Launch of the ‘Try & Tell’ Program
December 7, 2017
BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives
November 13, 2017
BioElectronics to Showcase Products at World's Largest Medical Tradeshow
November 9, 2017
BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch)
November 6, 2017
BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain
October 16, 2017
BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)
September 25, 2017
UPDATE - Letter from BioElectronics' (OTC PINK: BIEL) President to Investors
August 29, 2017
Letter from BioElectronics' (OTC PINK: BIEL) President to Investors
August 28, 2017
UPDATE - BioElectronics' President Discusses Company's Many Opportunities
August 22, 2017
BioElectronics' President Discusses Company's Many Opportunities
August 22, 2017
BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing
August 22, 2017
BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy)
August 8, 2017
BioElectronics Wins the Orthopedics This Week 2017 Sports Medicine Technology Award
August 2, 2017
BioElectronics to Present at 2017 UK Community Pharmacists' Meeting
June 30, 2017
BioElectronics Announces Health Economics Study
June 29, 2017
BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy)
May 30, 2017
BioElectronics Expands into Tesco in the UK Market
May 17, 2017
BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis
April 20, 2017
BioElectronics to Launch Educational Strategy: ActiPatch as the First Line of Defense Against Opioid Pain Medication
April 18, 2017
BioElectronics to Present Research at 13th World Congress of International Neuromodulation Society
April 11, 2017
BioElectronics Participates At 2017 Australian Pain Society 37th Annual Scientific Meeting
April 7, 2017
BioElectronics' ActiPatch Exhibits At Australia's Major Pharmaceutical Event
March 13, 2017
BioElectronics Appoints an Indian Subcontinent Distributor
March 6, 2017
BioElectronics Initiates US Over-the-Counter (Non Prescription) Sales Of Its FDA Cleared Drug-free Pain Relief Medical Devices
March 2, 2017
BioElectronics Corporation Letter from the President
February 28, 2017
BioElectronics Announces ActiPatch(R) Available on Amazon
February 9, 2017
BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch(R) Musculoskeletal Pain Therapy
February 6, 2017